| Literature DB >> 31850306 |
Pei Wang1, Xin Chen1,2, Hao Wang1, Shengzhuo Huang1, Caihong Cai1, Jingzhe Yuan1, Guoliang Zhu3, Xinglian Xu2, Wenli Mei1, Haofu Dai1.
Abstract
Four picrotoxane-type sesquiterpenes, dendroterpene A-D (1-4), together with four known compounds (5-8), were isolated from the stems of Dendrobium nobile Lindl. Their structures were elucidated by spectroscopic analysis, X-ray diffraction analysis, analysis of the ECD data according to the Klyne's lactone sector rule, and quantum ECD calculation. Compounds 1 and 2 are two new picrotoxane-type sesquiterpenes with a new carbon skeleton containing a formamide group, which may be derived from the previously reported dendrobiumane B skeleton by the C(9)-C(11) carbon bond cleavage. Compounds 3, 5, 6, and 8 exhibited inhibitory activity against α-glycosidase. Compounds 5 and 6 were cytotoxic against SGC-7901, K562, A549, BEL-7402, and Hela cell lines.Entities:
Keywords: Dendrobium nobile Lindl; cytotoxicity; picrotoxane; sesquiterpenes; α-glycosidase inhibitor
Year: 2019 PMID: 31850306 PMCID: PMC6895213 DOI: 10.3389/fchem.2019.00812
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
1H (500 MHz) and 13C (125 MHz) NMR Data of compounds 1–4.
| 1 | 52.5, C | – | 53.3, C | – | 47.8, C | – | 50.4, C | – |
| 2 | 51.2, CH | 4.24, s | 49.0, CH | 4.18, d, (9.7) | 81.5, CH | 4.28,d, (3.6) | 81.6, CH | 4.25, d, (3.6) |
| 3 | 84.5, CH | 4.34, brd, (5.5) | 83.2, CH | 4.33, brd, (5.6) | 77.9, CH | 4.75,dd, (3.6, 5.6) | 77.5, CH | 4.79, dd, (3.6, 5.1) |
| 4 | 52.5, CH | 2.02, m | 52.3, CH | 2.01, ddd, (4.7, 4.7, 11.2) | 50.9, CH | 2.29,ddd, (5.0,5.0,11.7) | 51.1, CH | 2.27, m |
| 5 | 46.1, CH | 2.28, t, (4.3) | 51.0, CH | 2.47, d, (4.7) | 43.4, CH | 2.57, dd, (4.3,5.6) | 43.2, CH | 2.57, dd, (4.3, 5.8) |
| 6 | 42.5, CH | 2.33, m | 80.6, C | – | 43.6, CH | 2.20, m | 44.9, CH | 2.31, m |
| 6-OH | – | – | – | 5.40, brs | – | – | – | – |
| 7 | 36.9, CH2 | 2.69, ddd, | 46.1, CH2 | 2.64, brd, (15.1) | 32.4, CH2 | 2.15, m | 29.7, CH2 | 2.07, m; 2.36, m |
| 8 | 130.3, CH | 5.51, dd, (2.3, 5.5) | 137.3, CH | 5.79, brd, (6.3) | 27.8, CH2 | 2.01, m; 2.14, m | 38.5, CH2 | 1.82, m; 2.28, m |
| 9 | 136.6, CH | 5.63, m | 127.7, CH | 5.47, d, (6.3) | 55.2, CH | 2.77,t, (9.4) | 85.1, C | – |
| 10 | 27.3, CH3 | 1.04, s | 22.3, CH3 | 0.96, s | 31.3, CH3 | 1.52, s | 24.3, CH3 | 1.43, s |
| 11 | 163.7, CH | 8.09, s | 161.7, CH | 8.12, s | 177.1, C | – | 177.2, C | – |
| 12-NH | – | – | – | 8.51, d, (9.6) | – | – | – | – |
| 13 | 26.4, CH | 1.84, m | 26.4, CH | 2.36, m | 24.8, CH | 1.75, m | 24.8, CH3 | 1.84, m |
| 14 | 20.1, CH | 0.95, d, (6.6) | 22.2, CH3 | 1.00, d, (6.1) | 20.6, CH3 | 1.04, d, (6.5) | 20.7, CH3 | 1.04, d, (6.5) |
| 15 | 21.0, CH3 | 0.93, d, (6.6) | 20.3, CH3 | 0.89, d, (6.6) | 21.4, CH3 | 1.02, d, (6.5) | 21.5, CH3 | 1.02, d, (6.6) |
| 16 | 180.3, C | – | 176.5, C | – | 177.5, C | – | 177.5, C | – |
measured in CD3OD;
measured in DMSO-d6;
measured in CDCl.
Figure 2Key HMBC () and 1H–1H COSY (−) correlations of compounds 1–4.
Figure 3ROESY () correlations of compounds 1–3.
Figure 4Molecular plots of compounds 1, 2, and 4.
Figure 5Application of lactone sector rule to compounds 1 and 2.
Figure 6Measured ECD and TD-DFT calculated ECD curves of compound 3.
Figure 1The structures of compounds 1–8.
Figure 7Hypothetical biogenetic pathway of compounds 1–4.